Press releases
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- Prothena to Report First Quarter 2024 Financial Results on May 8
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
- Prothena to Participate in Upcoming Healthcare Conferences
Key statistics
On Wednesday, Prothena Corporation PLC (0PT:BER) closed at 19.90, 8.15% above its 52-week low of 18.40, set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.90 |
---|---|
High | 20.40 |
Low | 19.90 |
Bid | 19.80 |
Offer | 20.40 |
Previous close | 19.90 |
Average volume | 8.20 |
---|---|
Shares outstanding | 53.77m |
Free float | 47.09m |
P/E (TTM) | -- |
Market cap | 1.16bn USD |
EPS (TTM) | -3.25 USD |
Data delayed at least 15 minutes, as of May 22 2024 19:21 BST.
More ▼